Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

55 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Pegfilgrastim in Patients Receiving First-Line FOLFOX/Bevacizumab or FOLFIRI/Bevacizumab for Locally Advanced or Metastatic Colorectal Cancer: Final Results of the Pegfilgrastim and Anti-VEGF Evaluation Study (PAVES).
Pinter T, Klippel Z, Cesas A, Croitoru A, Decaestecker J, Gibbs P, Hotko Y, Jassem J, Kurteva G, Novotny J, O'Reilly S, Salek T, Reiner M, Morrow PK, Choi MR, Whittaker S, Blanke C. Pinter T, et al. Among authors: decaestecker j. Clin Colorectal Cancer. 2017 Jun;16(2):103-114.e3. doi: 10.1016/j.clcc.2016.08.008. Epub 2016 Sep 7. Clin Colorectal Cancer. 2017. PMID: 28038865 Clinical Trial.
NPY Methylated ctDNA is a Promising Biomarker for Treatment Response Monitoring in Metastatic Colorectal Cancer.
Janssens K, Vanhoutte G, Lybaert W, Demey W, Decaestecker J, Hendrickx K, Rezaei Kalantari H, Zwaenepoel K, Pauwels P, Fransen E, Op de Beeck K, Van Camp G, Rolfo C, Peeters M. Janssens K, et al. Among authors: decaestecker j. Clin Cancer Res. 2023 May 1;29(9):1741-1750. doi: 10.1158/1078-0432.CCR-22-1500. Clin Cancer Res. 2023. PMID: 36716292 Clinical Trial.
Unexpected outcome of a sigmoid lesion believed to be malignant.
Ferdinande K, Harlet L, Decaestecker J, De Wulf D. Ferdinande K, et al. Among authors: decaestecker j. Acta Gastroenterol Belg. 2023 Apr-Jun;86(2):383-384. doi: 10.51821/86.2.11927. Acta Gastroenterol Belg. 2023. PMID: 37428178 Free article.
An underrecognized cause of hepatomegaly in uncontrolled type I diabetes.
Ferdinande K, Decaestecker J, Seynhaeve L, Steenkiste E, De Vloo C. Ferdinande K, et al. Among authors: decaestecker j. Acta Gastroenterol Belg. 2023 Jul-Sep;86(3):507-508. doi: 10.51821/86.3.12257. Acta Gastroenterol Belg. 2023. PMID: 37814573 Free article. No abstract available.
The risk of early occurrence and recurrence of hepatocellular carcinoma in hepatitis C-infected patients treated with direct-acting antivirals with and without pegylated interferon: A Belgian experience.
Bielen R, Moreno C, Van Vlierberghe H, Bourgeois S, Mulkay JP, Vanwolleghem T, Verlinden W, Brixco C, Decaestecker J, de Galocsy C, Janssens F, Van Overbeke L, Van Steenkiste C, D'Heygere F, Cool M, Wuyckens K, Nevens F, Robaeys G. Bielen R, et al. Among authors: decaestecker j. J Viral Hepat. 2017 Nov;24(11):976-981. doi: 10.1111/jvh.12726. Epub 2017 Aug 3. J Viral Hepat. 2017. PMID: 28504854
55 results